General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Padovese V et al. - Many atypical and severe presentations were seen, and a poor response to first-line antileishmanial drugs was observed. Resistance to antimonials is of concern and cost-effective therapeutic schemes need to be developed. The cost-effectiveness of pentamidine isethionate has to be determined in a larger population.


Today in Derm Infectious Disease...keeping you current

Erysipeloid: a review
Clinical and Experimental Dermatology, 09/18/09

A practical approach to using methotrexate
Dermatology in Practice, 10/09/09

Bed bugs - What the GP needs to know
Australian Family Physician, 11/09/09

Today in Tropical/Parasitology...keeping you current

Drugs for preventing malaria in travellers
Cochrane Reviews, 10/23/09

Bed bugs - What the GP needs to know
Australian Family Physician, 11/09/09

Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial
The Lancet, 11/02/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address